0001735427-23-000003.txt : 20231012 0001735427-23-000003.hdr.sgml : 20231012 20231012164328 ACCESSION NUMBER: 0001735427-23-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231012 DATE AS OF CHANGE: 20231012 EFFECTIVENESS DATE: 20231012 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Apollo Neuroscience, Inc. CENTRAL INDEX KEY: 0001735427 IRS NUMBER: 820664771 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-474027 FILM NUMBER: 231323161 BUSINESS ADDRESS: STREET 1: 1942 FIFTH AVENUE CITY: PITTSBURGH STATE: PA ZIP: 15219 BUSINESS PHONE: (518) 312-0567 MAIL ADDRESS: STREET 1: 1942 FIFTH AVENUE CITY: PITTSBURGH STATE: PA ZIP: 15219 D/A 1 primary_doc.xml X0708 D/A LIVE 0001735427 Apollo Neuroscience, Inc. 1942 FIFTH AVENUE PITTSBURGH PA PENNSYLVANIA 15219 (518) 312-0567 DELAWARE Neural Impact, Inc. None Corporation true Kathryn Fantauzzi 1942 Fifth Avenue Pittsburgh PA PENNSYLVANIA 15219 Executive Officer Director Promoter Other Health Care Decline to Disclose 06b true 0001735427-23-000001 2023-02-09 false true true Simple Agreement for Future Equity (SAFE) false 0 10000000 5995000 4005000 false 10 0 0 0 false Apollo Neuroscience, Inc. Kathryn Fantauzzi Kathryn Fantauzzi CEO 2023-10-12